JI’AN, JIANGXI, China, December 21, 2022 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a Chinese pharmaceutical manufacturer and distributor, today announced that its products will be available on December 12, 2022. It was included in the first edition of the catalog of medicines for patients infected with COVID-19 (the “catalog”) published by the Beijing Health Commission on May 12. Paracetamol, vitamin C silver bridge tablets, acetaminophen tablets, metamizole sodium tablets.
This catalog supplements the list of medicines recommended by the ninth edition of the National Diagnostic and Treatment Plan. The catalog recommends 67 traditional Chinese medicine products for 6 medical symptoms such as fever and sore throat, and 41 western medicine products for 4 clinical symptoms such as cough and sputum. In addition to hospitals, patients can also purchase medicines included in the catalog from channels such as retail pharmacies and e-commerce platforms according to their needs.
Gang Lai, Chairman and CEO of Universe Pharmaceuticals INC, commented: Currently, we are receiving increasing orders for three products: Vanlangen granules, strong loquat extract, and pediatric paracetamol. We will strive to optimize our supply chain system to meet the increased demand and ensure sufficient supply of these three products for people to fight the symptoms of COVID-19. “
About Universe Pharmaceuticals
Universe Pharmaceuticals Inc., headquartered in Ji’an, Jiangxi, China, is a manufacturer and distributor of pharmaceuticals in China. The Company specializes in manufacturing, marketing, selling and distributing traditional Chinese herbal medicine derivatives for the elderly to address physical conditions in the aging process and promote general health. It is an object. The Company also distributes and sells biopharmaceuticals, medical devices, herbal medicines and dietary supplements manufactured by third-party pharmaceutical companies. Currently, the company’s products are sold in 30 provinces in China. For more information, please visit his website for the following companies: http://www.universe-pharmacy.com/.
Forward-Looking Statements
All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on our current expectations and projections regarding future events and financial trends, and are based on our financial condition, results of operations and business strategy. , and may affect our financial needs. Investors can identify these forward-looking statements by the following words or phrases: “May,“ “intention,“ “Predict,“ “Predict,“ “target,“ “Quote,“ “intended to“ “schedule,“ “believe,“ “potential,“ “Continue,“ “likely to“ or similar expressions. We undertake no obligation to update forward-looking statements to reflect subsequent events or circumstances or changes in expectations, except as required by law. Although we believe the expectations expressed in these forward-looking statements are reasonable, we cannot give any assurance that such expectations will prove to be correct. Please review our registration statements and other regulatory filings for other factors that may affect future results. US Securities and Exchange Commission.
For more information, please contact:
Ascent Investors Relations LLC
Tina Xiao
president
Phone: 917-609-0333
Email: [email protected]
